The value of fast-acting insulin aspart compared with insulin aspart for patients with diabetes mellitus treated with bolus insulin from a UK health care system perspective

BACKGROUND: Fast-acting insulin aspart is a new formulation of the rapid-acting insulin analogue insulin aspart and represents an advancement over current rapid-acting insulin analogues in terms of onset of action and postprandial glucose control. The objective of the current analysis was to demonst...

Descripción completa

Detalles Bibliográficos
Autores principales: Leelarathna, Lalantha, Ashley, Donna, Fidler, Carrie, Parekh, Witesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022975/
https://www.ncbi.nlm.nih.gov/pubmed/29977497
http://dx.doi.org/10.1177/2042018818766816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022975/
https://www.ncbi.nlm.nih.gov/pubmed/29977497
http://dx.doi.org/10.1177/2042018818766816

Ejemplares similares